06/24/2022 / By News Editors
(Article by Steve Kirsch republished from SteveKirsch.Substack.com)
This preprint paper, Serious Adverse Events of Special Interest Following mRNA Vaccination in Randomized Trials, was written by a team of highly credible authors and is now undergoing peer review. It points out that the vaccines carry more risk than benefit.
Big whoops. That’s not what the CDC and FDA have been saying. This is really embarrassing for them that now others are starting to discover what I’ve been saying for over a year now.
Don’t expect the mainstream media to cover this or ask any questions. That’s not the way it works.
Woo hoo!
And this just in from Tennessee:
Once this paper is published, it then becomes “misinformation” according to the State of California (assuming they pass AB-2098 which seems likely). That means that any physician relying on this paper to counsel their patients could have their license to practice medicine taken away.
That’s how things work in California. It’s not about “follow the science” anymore. That is not a defense. As a doctor you must “follow the herd.” If you disagree with the masses, even if you are right, kiss your medical license good-bye!!
But there is a hidden feature of AB-2098 that nobody is talking about: it is IMPOSSIBLE for doctors to shift position on a topic like vaccine safety. Either 100% of the doctors are for it, or 100% will be against it. There can’t be a middle ground or you get your license revoked so everyone has to stick with the initial narrative. That means the vaccines will always be safe and effective in California even when they aren’t.
If that doesn’t enforce conformity, I don’t know what will.
Read more at: SteveKirsch.Substack.com
Tagged Under:
big government, Big Pharma, California, children's health, conspiracy, covid19, medical fascism, Medical Tyranny, pandemic, pharmaceutical fraud, truth, vaccine damage, vaccine injury, vaccine wars, vaccines
This article may contain statements that reflect the opinion of the author
COPYRIGHT © 2017 BIG PHARMA NEWS